Cytokinetics shares owned by Finepoint Capital
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Finepoint Capital
from 13F filings
Historical chart of Finepoint Capital investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Finepoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $13M | 432k | 29.46 |
| 2023-06-30 | $12M | 369k | 32.62 |
| 2023-03-31 | $15M | 414k | 35.19 |
| 2022-12-31 | $19M | 403k | 45.82 |
| 2022-09-30 | $18M | 381k | 48.45 |
| 2022-06-30 | $17M | 419k | 39.29 |